Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Veterinary bovine ephemeral fever inactivated vaccine and large-scale production method thereof

A bovine epidemic fever and production method technology, which is applied in the field of vaccine preparation in biomedicine, can solve the problems of high labor cost, large batch-to-batch variation, and low vaccine efficacy, and achieve high automation, small immune dose, and toxin production efficiency high effect

Pending Publication Date: 2021-07-16
JINYUBAOLING BIO PHARMA CO LTD
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparation of these two viral antigens requires adherent cell culture, and the cells need to be digested and divided into bottles during the large-scale production of vaccines, which has a high risk of contamination; moreover, these operations need to be done manually, and a large number of manual operations make labor costs high
In addition, the number of adherent cells is small, and there are technical defects such as low toxin production efficiency, low vaccine efficacy, large immune doses required to achieve the same immune effect, and large batch-to-batch differences.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Veterinary bovine ephemeral fever inactivated vaccine and large-scale production method thereof
  • Veterinary bovine ephemeral fever inactivated vaccine and large-scale production method thereof
  • Veterinary bovine ephemeral fever inactivated vaccine and large-scale production method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Embodiment 1, isolation and identification of bovine epidemic fever virus

[0038] The bovine epidemic fever virus strain used in the embodiment is isolated from a suspected bovine epidemic fever cattle in a farm in Nanyang City, Henan Province. The specific isolation operation is as follows:

[0039] Collect sick cattle anticoagulant blood, utilize bovine epidemic fever (bovine epidemic fever virus) fluorescent quantitative PCR method (with reference to the primers and PCR detection methods disclosed for bovine epidemic fever virus among CN109355431A) detect this anticoagulant blood, if bovine epidemic fever shows Positive, indicating that the anticoagulant blood contains bovine epidemic fever antigen; the anticoagulant blood was frozen and thawed 3 times and inoculated on BHK21-C13 monolayer cells (stored in Jinyu Baoling Biopharmaceutical Co., Ltd.), and the culture medium contained 8 %-10% newborn bovine serum in DMEM solution, cultured at 37°C for 48-72h, and when ...

Embodiment 2

[0075] Embodiment 2, the optimization of bovine epidemic fever virus inoculation and culture conditions

[0076] 2.1. Determination of optimal harvesting time of virus antigen:

[0077] The F6 generation seed virus in Example 1 was passed on for 10 generations to obtain the F16 generation seed virus, which was inoculated in BHK21-C13 suspension cells according to 0.2% (volume percentage content) (the BHK21-C13 suspension cell culture is described in detail in the following embodiment 3) method), the initial seeding density of cells was 2×10 6 cells / ml, cultured at 37°C, and the culture medium was a special medium for suspension (1.15g / L sodium bicarbonate was added to BBSM medium (purchased from Beijing Qingda Tianyi Technology Co., Ltd., product code: MD910), and 3% to 5% (percentage by volume) of newborn bovine serum, adjust the pH value to 7.2 ± 0.5), take samples when culturing 24, 48, 72, 96, and 120h respectively to observe the bovine epidemic fever virus infection of B...

Embodiment 3

[0097] Embodiment 3, the production of bovine epidemic fever inactivated vaccine

[0098] This embodiment utilizes the bovine epidemic fever virus strain that above-mentioned embodiment 1 isolates as seed virus as example, according to the virus inoculation and culture condition determined in above-mentioned embodiment 2, cultivate bovine epidemic fever virus seed virus with the BHK21-C13 cell of suspension culture, Thereby the virus antigen used for producing the bovine epidemic fever inactivated vaccine is prepared. Wherein the existing bovine epidemic fever virus strain can also be used as the seed virus, and the claimed technical effect of the present invention can also be realized. The production of bovine epidemic fever inactivated vaccine specifically includes the following operations.

[0099] 3.1 Large-scale cultivation of BHK21-C13 suspension cells in bioreactors

[0100] 3.1.1. Recovery of BHK21-C13 cells in suspension culture

[0101] Take out a frozen BHK21-C13...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a veterinary bovine ephemeral fever inactivated vaccine and a large-scale production method thereof, and belongs to the technical field of vaccine production. The method provided by the invention comprises the steps of performing cell culture by utilizing a suspension culture process, performing virus suspension culture, performing virus antigen solution clarification, performing concentration and purification, performing inactivation and performing emulsification vaccine preparation, and the method can realize mass proliferation of the bovine ephemeral fever virus, improves the content and yield of the virus antigen, and has a high automation degree; The synergistic effect of all the steps can jointly improve the quality and stability of the vaccine, and the technical problems that the yield of the bovine ephemeral fever virus produced by cell culture through a traditional spinner bottle or microcarrier process is low, the process is tedious, the difference between virus antigen batches is large, the vaccine efficacy is low, the vaccine validity period is short and the like are solved.

Description

technical field [0001] The invention belongs to the technical field of vaccine preparation in biomedicine, and in particular relates to a veterinary bovine epidemic fever inactivated vaccine and a large-scale production method thereof. Background technique [0002] Bovine ephemeral fever (BEF) is an acute, non-contact infectious disease of cattle, dairy cattle, beef cattle and buffalo caused by bovine ephemeral fever virus. The disease is characterized by sudden high fever, shortness of breath, lacrimation, and severe catarrhal inflammation and dyskinesia of the digestive organs. Most of the sick cattle infected with the disease can return to normal after 2-3 days, so it is also called three-day fever or temporary fever. The disease is rapid and violent, but mostly benign. However, the disease can cause large herds of cattle to fall ill and significantly reduce the milk production of dairy cows. [0003] The bovine epidemic fever vaccine is one of the most important ways t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/205A61P31/14C12N7/00C12N7/06C12R1/93
CPCA61K39/12A61P31/14C12N7/00A61K2039/5252C12N2760/20051C12N2760/20034C12N2760/20063
Inventor 孔彩平郝鹏刘国英杨波方建国朱旭刘建奇王秀明李雪峰
Owner JINYUBAOLING BIO PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products